KINICITI

kiniciti-logo

Kiniciti is a new Welsh, Carson, Anderson & Stowe platform established to partner with companies that have the potential to transform the cell and gene therapy ecosystem and deliver the promise of these therapies to impact patients’ lives. Bringing novel treatments to the patients who need them most — in an economically viable way — is too often crippled by persistent bottlenecks, constraints and inefficiencies in the development, manufacturing and delivery of those innovations

#SimilarOrganizations #People #Financial #More

KINICITI

Social Links:

Industry:
Finance Genetics Medical Venture Capital

Founded:
2020-01-01

Status:
Active

Contact:
(212) 650-4104

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Microsoft Exchange Online


Similar Organizations

w-health-ventures-logo

W Health Ventures

W Health Ventures invests in digital health companies that are transforming healthcare delivery.


Current Advisors List

michelle-dipp_image

Michelle Dipp Board Member @ KINICITI
Board_member
2021-11-01

Current Employees Featured

not_available_image

Geoffrey Glass
Geoffrey Glass Chief Executive Officer @ KINICITI
Chief Executive Officer
2021-01-01

not_available_image

Jason Conner
Jason Conner Chief Strategy Officer @ KINICITI
Chief Strategy Officer
2021-01-01

Founder


not_available_image

Geoffrey Glass

Investors List

biospring-partners_image

Biospring Partners

Biospring Partners investment in Funding Round - KINICITI

Investments List

Date Company Article Money raised
2021-11-16 Ncardia KINICITI investment in Venture Round - Ncardia 60 M USD

More informations about "KINICITI"

KINICITI | Kiniciti | Smart Partnerships that Advance Cell and Gene …

Current Kiniciti Operating Companies Include: Cellistic’s goal is to meet a distinct and increasingly important market need: To develop novel iPSC-based manufacturing technologies that give therapeutic developers access to the scale they need to make their cell therapies a reality. …See details»

KINICITI - Crunchbase Investor Profile & Investments

Kiniciti is a new Welsh, Carson, Anderson & Stowe platform established to partner with companies that have the potential to transform the cell and gene therapy ecosystem and …See details»

Kiniciti | Investment Profile - WCAS

Kiniciti is a buy-and-build platform focused on investing in and supporting non-therapeutic service, tools and technology companies that enable innovation and development of cell and gene …See details»

Our investment in Kiniciti - Biospring Partners

Apr 26, 2022 Kiniciti, a platform company of leading private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and Biospring Partners, invests in and partners with companies that have the potential to transform and strengthen …See details»

Kiniciti - VentureRadar

Kiniciti, a platform company of leading private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and Biospring Partners, invests in and partners with companies that have the …See details»

Kiniciti Company Profile 2025: Valuation, Funding

Kiniciti General Information Description. Provider of resources, expertise, and capital intended to help life science companies scale and deliver compelling …See details»

Kiniciti Company Profile | Management and Employees List

Kiniciti is an investment firm that invests in and partners with companies that have the potential to transform and strengthen the cell and gene therapy ecosystem. They are headquartered in …See details»

KINICITI - Org Chart, Teams, Culture & Jobs - The Org

Kiniciti is a new WCAS platform established to partner with companies that have the potential to transform the cell and gene therapy. Industries. Health Care, Venture Capital. Headquarters. …See details»

Kiniciti — Inveniv

Kiniciti’s corporate mark was designed to be elegant and simple, with a subtle reference to the DNA strands at the heart of cell and gene therapy the company’s funded entities pursue. A …See details»

KINICITI - Investments, Portfolio & Company Exits - Crunchbase

Kiniciti is a new WCAS platform established to partner with companies that have the potential to transform the cell and gene therapy. New. Resources. ... Which industries has this …See details»

Kiniciti: Revenue, Competitors, Alternatives - Growjo

Kiniciti is a new Welsh, Carson, Anderson & Stowe platform established to partner with companies that have the potential to transform the cell and gene therapy ecosystem and …See details»

Welsh Carson Anderson & Stowe acquires KINICITI - Crunchbase

Feb 1, 2021 KINICITI Kiniciti is a new WCAS platform established to partner with companies that have the potential to transform the cell and gene therapy Acquiring Organization: Welsh …See details»

Welsh, Carson, Anderson & Stowe Commits $250 Million in a …

Feb 1, 2021 Kiniciti's leadership team includes Geoffrey Glass, Chief Executive Officer, and Jason Conner, Chief Strategy Officer. For more than 25 years, Mr. Glass has helped lead …See details»

Kiniciti Company Profile: , Investments, Contact Information, News ...

Kiniciti is a new Welsh, Carson, Anderson & Stowe platform established to partner with companies that have the potential to transform the cell and gene therapy ecosystem and …See details»

Kiniciti, Ncardia, and the Future of Cell & Gene Therapy

Apr 26, 2022 In November 2021, we were pleased to announce our investment in Kiniciti, a Cell & Gene Therapy (“CGT”) aggregator. Later in November, Kiniciti announced its first strategic …See details»

Kiniciti Welcomes Two Cell and Gene Therapy Industry Leaders to …

Mar 21, 2021 Kiniciti invests in, and partners with, companies that have the potential to transform and strengthen the cell and gene therapy ecosystem. With a highly tailored, …See details»

Ncardia Secures $60+ Million To Enhance And Expand Leading I …

“Kiniciti is uniquely suited to help Ncardia expand globally and to support our planned investment into GMP capabilities for our iPSC-based cell therapy platforms.” “Combining Ncardia’s …See details»

KINICITI - Funding, Financials, Valuation & Investors - Crunchbase

Nov 10, 2021 KINICITI has raised 1 round. This was a Venture - Series Unknown round raised on Nov 10, 2021. KINICITI is funded by 2 investors. Welsh Carson Anderson & Stowe and …See details»

KINICITI - Contacts, Employees, Board Members, Advisors & Alumni

KINICITI has 1 board member or advisor, Michelle Dipp. Contacts. Edit Contacts Section. Job Department. Protected Content. Vice President, Corporate Development. Non-Management, …See details»

Welsh, Carson, Anderson & Stowe Commits $250 Million

Feb 1, 2021 Kiniciti's leadership team includes Geoffrey Glass, Chief Executive Officer, and Jason Conner, Chief Strategy Officer. For more than 25 years, Mr. Glass has helped lead …See details»

linkstock.net © 2022. All rights reserved